.jpg "Rachel Rosovsky, MD, MPH photo")
Assistant Professor, Harvard Medical school
Massachusetts General Hospital
Boston, Massachusetts, United States
Dr. Rachel Rosovsky, MD, MPH, hematologist at Massachusetts General Hospital MGH), provides clinical care full-time, supervises trainees and conducts research in area of thrombosis and hemostasis. She is Associate Professor of Medicine at Harvard Medical School, Director of Thrombosis Research in Division of Hematology and Co-Chair of MGH’s Thrombosis Committee. Dr. Rosovsky is President-Elect of Pulmonary Embolism Response Team (PERT) Consortium and creator/director of PERT multidisciplinary follow up clinic at MGH. She is on Executive Committee for Venous thromboEmbolism Network US and serves on Committee on Quality for American Society of Hematology. She has presented/published widely in this area and through lecturing, research, and written works, she has sought to improve care of patients with VTE and advance understanding and treatment of this condition.
Saturday, February 25, 2023
4:30 PM – 5:30 PM ET
Disclosure(s): Abbott: Consultant (Ongoing); BMS: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Dova: Consultant/Advisory Board (Terminated); Inari Medical: Consultant (Ongoing); Jannsen: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); penumbra: Consultant/Advisory Board (Ongoing), National Lead Investigator (Ongoing)
Sunday, February 26, 2023
9:30 AM – 9:40 AM ET
Disclosure information not submitted.
Monday, February 27, 2023
6:45 AM – 7:55 AM ET
Disclosure(s): Abbott: Consultant (Ongoing); BMS: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Dova: Consultant/Advisory Board (Terminated); Inari Medical: Consultant (Ongoing); Jannsen: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); penumbra: Consultant/Advisory Board (Ongoing), National Lead Investigator (Ongoing)
Monday, February 27, 2023
7:32 AM – 7:40 AM ET
Disclosure(s): Abbott: Consultant (Ongoing); BMS: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Dova: Consultant/Advisory Board (Terminated); Inari Medical: Consultant (Ongoing); Jannsen: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); penumbra: Consultant/Advisory Board (Ongoing), National Lead Investigator (Ongoing)
Monday, February 27, 2023
7:40 AM – 7:55 AM ET
Disclosure(s): Abbott: Consultant (Ongoing); BMS: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); Dova: Consultant/Advisory Board (Terminated); Inari Medical: Consultant (Ongoing); Jannsen: Consultant/Advisory Board (Terminated), Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Terminated); penumbra: Consultant/Advisory Board (Ongoing), National Lead Investigator (Ongoing)